Loading stock data…
Loading stock data…
US$8.79
Get one email when SCLX crosses your level. Checked every 15 minutes during market hours.
▼ -0.43 (-4.66%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
61.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.96
Bearish momentumMACD below its signal line (0.97).
50-day average
6.03
Price aboveShort-term trend reference.
200-day average
7.29
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - General
Scilex Holding Company is an innovative biopharmaceutical firm focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain treatment. Its portfolio features ZTLido, a proprietary patch with advanced adhesion and delivery technology for optimized transdermal drug transport to localized pain areas; Elyxyb, the only liquid ready-to-use oral solution providing fast, long-lasting migraine relief; and Gloperba, an anti-inflammatory oral solution…
www.scilexholding.com0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-07-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-06-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-05-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-07-08 | 0.04 | 0.05 | ✓ Beat |
| 2026-04-10 | -0.47 | -1.17 | ✗ Miss |
| 2026-03-16 | 2.01 | 2.62 | ✓ Beat |
| 2026-02-11 | 2.08 | 2.1 | ✓ Beat |
| 2025-12-10 | -0.01 | -0.05 | ✗ Miss |
| 2025-11-14 | -0.41 | -21.29 | ✗ Miss |
| 2025-08-13 | -0.91 | -7.42 | ✗ Miss |
| 2025-05-14 | -0.01 | -1.73 | ✗ Miss |